1. Home
  2. BWAY vs FDBC Comparison

BWAY vs FDBC Comparison

Compare BWAY & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • FDBC
  • Stock Information
  • Founded
  • BWAY 2003
  • FDBC 1902
  • Country
  • BWAY Israel
  • FDBC United States
  • Employees
  • BWAY N/A
  • FDBC N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • FDBC Major Banks
  • Sector
  • BWAY Health Care
  • FDBC Finance
  • Exchange
  • BWAY Nasdaq
  • FDBC Nasdaq
  • Market Cap
  • BWAY 207.4M
  • FDBC 226.2M
  • IPO Year
  • BWAY 2019
  • FDBC N/A
  • Fundamental
  • Price
  • BWAY $8.76
  • FDBC $40.34
  • Analyst Decision
  • BWAY Strong Buy
  • FDBC
  • Analyst Count
  • BWAY 3
  • FDBC 0
  • Target Price
  • BWAY $13.17
  • FDBC N/A
  • AVG Volume (30 Days)
  • BWAY 24.0K
  • FDBC 6.4K
  • Earning Date
  • BWAY 05-13-2025
  • FDBC 04-23-2025
  • Dividend Yield
  • BWAY N/A
  • FDBC 3.97%
  • EPS Growth
  • BWAY N/A
  • FDBC 32.67
  • EPS
  • BWAY 0.06
  • FDBC 3.76
  • Revenue
  • BWAY $41,016,000.00
  • FDBC $81,621,000.00
  • Revenue This Year
  • BWAY $351.53
  • FDBC N/A
  • Revenue Next Year
  • BWAY $21.84
  • FDBC N/A
  • P/E Ratio
  • BWAY $57.37
  • FDBC $10.73
  • Revenue Growth
  • BWAY 29.04
  • FDBC 15.50
  • 52 Week Low
  • BWAY $5.13
  • FDBC $37.00
  • 52 Week High
  • BWAY $11.79
  • FDBC $61.21
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 47.80
  • FDBC 48.15
  • Support Level
  • BWAY $8.61
  • FDBC $40.54
  • Resistance Level
  • BWAY $9.09
  • FDBC $41.50
  • Average True Range (ATR)
  • BWAY 0.38
  • FDBC 1.20
  • MACD
  • BWAY 0.05
  • FDBC 0.29
  • Stochastic Oscillator
  • BWAY 58.73
  • FDBC 50.09

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About FDBC Fidelity D & D Bancorp Inc.

Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.

Share on Social Networks: